Amazon (NASDAQ: AMZN) announced that its pharmacy service will now offer GLP-1 medications, including Wegovy, Zepbound, and Foundayo, to eligible Medicare Part D patients for $50 per month.

Amazon Pharmacy said same-day delivery of GLP-1 medications is currently available in more than 3,100 U.S. cities, with plans to expand to nearly 4,500 cities by the end of 2026.